| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f6be7b5f316f050e9151b3afd8936f7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_451758c05b923e919f4993d1e9bf1d04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f97986c94313b4cf4d66c26670f78f3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 |
| filingDate |
2021-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02e307fe9f84e7dd744758abd1c6d86c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_34967289df5d1c8ed8a711b69bfaebf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8653275d0e0f58bb81480db56d97a473 |
| publicationDate |
2022-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022104150-A1 |
| titleOfInvention |
Triple combination to treat b-cell malignancies |
| abstract |
A triple combination of agents comprising: (i) a PI3K-delta selective inhibitor (umbralisib); (ii) an anti-CD20 antibody (ublituximab); and (iii) the Bruton's tyrosine kinase (BTK) inhibitor TG-1701 for use in treating B-cell malignancies. Kits for carrying out the claimed treatments are also provided. |
| priorityDate |
2020-11-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |